NFKB1 and prostate carcinoma: Therefore, the current study confirms the prior finding of a link between NF-κB/p65 and prostate cancer outcome and extends the observation by showing that nuclear localisation of NF-κB/p65 (the biologically active form) is specifically associated to outcome while cytoplasmic staining lacked prognostic value.